Artificial intelligence optimizes immune rejection prediction and management in heart transplantation: a structured narrative review - Report - MDSpire

Artificial intelligence optimizes immune rejection prediction and management in heart transplantation: a structured narrative review

  • By

  • Kaixin Chen

  • Junlin Lai

  • Yijie Luo

  • Chenghao Li

  • Guohua Wang

  • May 14, 2026

  • 0 min

Share

Clinical Report: Enhancing Prediction and Management of Immune Rejection in Heart Transplantation Through Artificial Intelligence

Overview

This narrative review highlights the potential of artificial intelligence (AI) to improve donor-recipient matching, enhance non-invasive rejection surveillance, and standardize pathological diagnosis in heart transplantation. Despite promising findings, the review emphasizes the need for more robust, multi-center studies to validate these AI applications in clinical practice.

Background

Heart transplantation is the gold standard for treating end-stage heart failure, yet its success is often hindered by challenges in immune rejection management. Traditional methods for donor-recipient matching and rejection monitoring are limited, leading to complications and suboptimal outcomes. The integration of AI presents an opportunity to address these critical issues and improve patient care.

Data Highlights

No numerical data available.

Key Findings

  • 3D-Convolutional Neural Networks (3D-CNNs) can accurately measure total cardiac volume for better anatomical matching.
  • Machine learning models outperform traditional regression in identifying risk factors for postoperative adverse events.
  • AI models using non-invasive biomarkers show high diagnostic accuracy for rejection, potentially reducing unnecessary endomyocardial biopsies by 56.8%.
  • AI improves sensitivity for detecting high-grade acute cellular rejection from 39.5% to 74.4% compared to manual assessments.
  • Generative adversarial networks (GANs) achieve a rejection region detection AUROC of 98.84%.
  • Most studies reviewed exhibit methodological limitations, including small sample sizes and lack of external validation.

Clinical Implications

Clinicians should consider the integration of AI tools in preoperative and postoperative management of heart transplant patients to enhance decision-making and reduce reliance on invasive procedures. However, the current evidence base necessitates cautious interpretation and further validation before widespread implementation.

Conclusion

AI holds significant promise for transforming heart transplantation practices, but further research is essential to overcome existing methodological limitations and ensure effective clinical application.

Related Resources & Content

  1. ISHLT, ISHLT Guidelines for the Care of Heart Transplant Recipients, 2023 -- Guidelines for heart transplant care
  2. Ewald GA et al., Gene-expression profiling for rejection surveillance after cardiac transplantation, 2023 -- Study on gene-expression profiling
  3. Nature Medicine, Deep learning-enabled assessment of cardiac allograft rejection from endomyocardial biopsies, 2022 -- Study on deep learning in rejection assessment
  4. Frontiers in Cardiovascular Medicine — Artificial intelligence in cardio-oncology: decoding mechanisms, predicting toxicity, and personalizing cancer therapy
  5. asco ai in oncology — Can AI Improve the Safety of Immune Checkpoint Inhibitors?
  6. The ASCO Post — Can AI Tool Improve Detection of Immune-Related Adverse Events in Patients With Cancer?
  7. The ASCO Post — Can AI Tool Improve Detection of Immune-Related Adverse Events in Patients With Cancer?
  8. Artificial intelligence in cardio-oncology: decoding mechanisms, predicting toxicity, and personalizing cancer therapy
  9. Can AI Improve the Safety of Immune Checkpoint Inhibitors?
  10. Can AI Tool Improve Detection of Immune-Related Adverse Events in Patients With Cancer?
  11. ISHLT Guidelines for the Care of Heart Transplant Recipients | ISHLT
  12. "Gene-expression profiling for rejection surveillance after cardiac tra" by Gregory A. Ewald and et al
  13. Deep learning-enabled assessment of cardiac allograft rejection from endomyocardial biopsies | Nature Medicine

Original Source(s)

Related Content